Optigo Biotherapeutics (“Optigo”), an ophthalmology company pioneering next-gen treatments for retinal diseases, today announced that Dr. Andreas Wallnöfer is joining its ...
EMBA Fall 2020 Cohort October 20, 2020 Recently, we welcomed our new fall cohort #8 of our Executive MBA (EMBA) program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback